Nov 12 (Reuters)-
TransGenic Group
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2026 Sep 30, 2025 Mar 31, 2027
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 7.07 6.22 14.00
(+13.6 pct) (-1.4 pct) (+6.3 pct)
Operating 161 mln 71 mln 260 mln
(+126.7 pct) (+88.5 pct)
Recurring 102 mln 83 mln 200 mln
(+23.2 pct) (+69.3 pct)
Net 88 mln 29 mln 150 mln
(+199.5 pct)
EPS 5.31 yen 1.77 yen 9.00 yen
Ann Div -- 0.00 yen 0.00 yen
-Q2 div 0.00 yen 0.00 yen --
-Q4 div -- 0.00 yen 0.00 yen
NOTE - TransGenic Group.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2342.TNov 12 (Reuters)-
TransGenic Group
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2026 Sep 30, 2025 Mar 31, 2027
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 7.07 6.22 14.00
(+13.6 pct) (-1.4 pct) (+6.3 pct)
Operating 161 mln 71 mln 260 mln
(+126.7 pct) (+88.5 pct)
Recurring 102 mln 83 mln 200 mln
(+23.2 pct) (+69.3 pct)
Net 88 mln 29 mln 150 mln
(+199.5 pct)
EPS 5.31 yen 1.77 yen 9.00 yen
Ann Div -- 0.00 yen 0.00 yen
-Q2 div 0.00 yen 0.00 yen --
-Q4 div -- 0.00 yen 0.00 yen
NOTE - TransGenic Group.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2342.T